| Lastest Insider Transactions Of Avalo Therapeutics, Inc. ( AVTX ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| AVTX | Avalo Therapeutics, Inc. | Goldman Jonathan | Directior | 2025-11-14 | Sell | 11,367 | 14.33 | 162,937 | 2025-11-17 16:05:46 |
| AVTX | Avalo Therapeutics, Inc. | Goldman Jonathan | Directior | 2025-11-14 | Option Exercise | 8,200 | 9.88 | 81,016 | 2025-11-17 16:05:46 |
| AVTX | Avalo Therapeutics, Inc. | Chan Mitchell | Directior | 2025-03-28 | Option Exercise | 3,167 | 0.00 | 0 | 2025-04-01 20:06:11 |
| AVTX | Avalo Therapeutics, Inc. | Goldman Jonathan | Directior | 2025-03-28 | Option Exercise | 3,167 | 0.00 | 0 | 2025-04-01 16:55:44 |
| AVTX | Avalo Therapeutics, Inc. | Truex Samantha | Directior | 2025-03-28 | Option Exercise | 3,167 | 0.00 | 0 | 2025-04-01 16:44:14 |
| AVTX | Avalo Therapeutics, Inc. | KANTOFF AARON | Directior | 2025-03-28 | Option Exercise | 3,167 | 0.00 | 0 | 2025-04-01 16:37:21 |
| AVTX | Avalo Therapeutics, Inc. | KAPLAN GILLA | Directior | 2025-03-28 | Option Exercise | 3,167 | 0.00 | 0 | 2025-04-01 16:30:23 |
| AVTX | Avalo Therapeutics, Inc. | Almenoff June Sherie | Directior | 2025-03-28 | Option Exercise | 3,167 | 0.00 | 0 | 2025-04-01 16:22:37 |
| AVTX | Avalo Therapeutics, Inc. | Sullivan Christopher Ryan | Chief Financial Officer | 2025-03-28 | Option Exercise | 24,200 | 0.00 | 0 | 2025-04-01 16:11:39 |
| AVTX | Avalo Therapeutics, Inc. | NEIL GARRY ARTHUR | Chief Executive Officer | 2025-03-28 | Option Exercise | 64,867 | 0.00 | 0 | 2025-04-01 16:01:04 |
| AVTX | Avalo Therapeutics, Inc. | Almenoff June Sherie | Directior | 2024-11-12 | Buy | 1,000 | 12.75 | 12,750 | 2024-11-14 17:21:55 |
| AVTX | Avalo Therapeutics, Inc. | ARMISTICE CAPITAL, LLC | 10% Owner | 2023-06-26 | Sell | 3,683,542 | 0.59 | 2,168,897 | 2023-06-28 18:12:57 |
| AVTX | Avalo Therapeutics, Inc. | Caissa Capital Management ltd. | 10% Owner | 2023-06-26 | Buy | 1,608,000 | 0.64 | 1,030,179 | 2023-06-27 16:10:55 |
| AVTX | Avalo Therapeutics, Inc. | Caissa Capital Management ltd. | 10% Owner | 2023-06-15 | Buy | 8,160 | 3.88 | 31,644 | 2023-06-20 16:04:50 |
| AVTX | Avalo Therapeutics, Inc. | Caissa Capital Management ltd. | 10% Owner | 2023-06-12 | Buy | 16,899 | 3.77 | 63,629 | 2023-06-14 16:14:07 |
| AVTX | Avalo Therapeutics, Inc. | Sullivan Christopher Ryan | Chief Financial Officer | 2023-06-09 | Buy | 511 | 3.42 | 1,748 | 2023-06-13 16:41:21 |
| AVTX | Avalo Therapeutics, Inc. | NEIL GARRY ARTHUR | CEO and Chairman of the Board | 2023-06-09 | Buy | 4,000 | 3.42 | 13,680 | 2023-06-13 16:39:36 |
| AVTX | Avalo Therapeutics, Inc. | Caissa Capital Management ltd. | 10% Owner | 2023-06-07 | Buy | 14,426 | 3.91 | 56,440 | 2023-06-09 16:24:16 |
| AVTX | Avalo Therapeutics, Inc. | Caissa Capital Management ltd. | 10% Owner | 2023-05-31 | Buy | 844 | 2.87 | 2,422 | 2023-06-02 16:22:32 |
| AVTX | Avalo Therapeutics, Inc. | Caissa Capital Management ltd. | 10% Owner | 2023-05-25 | Buy | 2,671 | 2.79 | 7,464 | 2023-05-30 16:27:36 |
| AVTX | Avalo Therapeutics, Inc. | Caissa Capital Management ltd. | 10% Owner | 2023-05-24 | Buy | 9,000 | 2.98 | 26,816 | 2023-05-24 16:15:01 |
| AVTX | Avalo Therapeutics, Inc. | Caissa Capital Management ltd. | 10% Owner | 2023-05-18 | Buy | 26,621 | 3.36 | 89,372 | 2023-05-22 16:30:01 |
| AVTX | Avalo Therapeutics, Inc. | Caissa Capital Management ltd. | 10% Owner | 2023-05-12 | Buy | 4,379 | 2.51 | 11,007 | 2023-05-16 17:23:43 |
| AVTX | Avalo Therapeutics, Inc. | Caissa Capital Management ltd. | 10% Owner | 2023-05-04 | Buy | 25,000 | 2.77 | 69,365 | 2023-05-08 16:10:27 |
| AVTX | Avalo Therapeutics, Inc. | Caissa Capital Management ltd. | 10% Owner | 2023-04-25 | Buy | 7,500 | 2.99 | 22,423 | 2023-04-27 16:07:38 |
| AVTX | Avalo Therapeutics, Inc. | Caissa Capital Management ltd. | 10% Owner | 2023-04-20 | Buy | 17,500 | 3.07 | 53,672 | 2023-04-24 16:32:46 |
| AVTX | Avalo Therapeutics, Inc. | Caissa Capital Management ltd. | 10% Owner | 2023-04-17 | Buy | 25,000 | 2.95 | 73,874 | 2023-04-18 16:08:00 |
| AVTX | Avalo Therapeutics, Inc. | Caissa Capital Management ltd. | 10% Owner | 2023-04-10 | Buy | 56,329 | 2.53 | 142,516 | 2023-04-11 16:51:36 |
| AVTX | Avalo Therapeutics, Inc. | ARMISTICE CAPITAL, LLC | 10% Owner | 2023-02-03 | Buy | 450,000 | 0.00 | 0 | 2023-02-09 16:32:03 |
| AVTX | Avalo Therapeutics, Inc. | NEIL GARRY ARTHUR | CEO and Chairman of the Board | 2022-12-09 | Buy | 2,083 | 4.42 | 9,207 | 2022-12-12 16:22:14 |
